BRPI0814835A2 - Composição farmacêutica oral de desmopressina - Google Patents
Composição farmacêutica oral de desmopressinaInfo
- Publication number
- BRPI0814835A2 BRPI0814835A2 BRPI0814835A BRPI0814835A2 BR PI0814835 A2 BRPI0814835 A2 BR PI0814835A2 BR PI0814835 A BRPI0814835 A BR PI0814835A BR PI0814835 A2 BRPI0814835 A2 BR PI0814835A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- desmopressin
- desmopressin oral
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200702215 | 2007-08-06 | ||
ES200702215A ES2319054B1 (es) | 2007-08-06 | 2007-08-06 | Composicion farmaceutica oral de desmopresina. |
PCT/ES2008/000539 WO2009027561A2 (es) | 2007-08-06 | 2008-08-01 | Composición farmacéutica oral de desmopresina |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0814835A2 true BRPI0814835A2 (pt) | 2015-03-31 |
BRPI0814835B1 BRPI0814835B1 (pt) | 2020-10-27 |
BRPI0814835B8 BRPI0814835B8 (pt) | 2021-05-25 |
Family
ID=40032884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0814835A BRPI0814835B8 (pt) | 2007-08-06 | 2008-08-01 | composição farmacêutica oral de desmopressina e seu uso |
Country Status (18)
Country | Link |
---|---|
US (1) | US8993521B2 (pt) |
EP (1) | EP2174652B1 (pt) |
JP (1) | JP5626682B2 (pt) |
CN (2) | CN106265494A (pt) |
AR (1) | AR068337A1 (pt) |
BR (1) | BRPI0814835B8 (pt) |
CY (1) | CY1118459T1 (pt) |
DK (1) | DK2174652T3 (pt) |
ES (2) | ES2319054B1 (pt) |
HR (1) | HRP20161676T1 (pt) |
HU (1) | HUE032667T2 (pt) |
LT (1) | LT2174652T (pt) |
MX (1) | MX2010001456A (pt) |
PL (1) | PL2174652T3 (pt) |
PT (1) | PT2174652T (pt) |
RU (1) | RU2474414C2 (pt) |
SI (1) | SI2174652T1 (pt) |
WO (1) | WO2009027561A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3400B1 (ar) | 2010-09-30 | 2019-10-20 | Ferring Bv | مركب صيدلاني من كاربيتوسين |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8306367L (sv) | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
ATE108326T1 (de) * | 1989-01-30 | 1994-07-15 | Corint Ltd | Wässerige desmopressin-cmc enthaltende arzneizubereitung. |
JP2653255B2 (ja) * | 1990-02-13 | 1997-09-17 | 武田薬品工業株式会社 | 長期徐放型マイクロカプセル |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
US5298256A (en) | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
IT1255460B (it) | 1992-07-28 | 1995-11-02 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive |
SE9300937L (sv) | 1993-03-19 | 1994-09-20 | Anne Fjellestad Paulsen | Komposition för oral administrering av peptider |
US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
SE9400918L (sv) | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
JP4321966B2 (ja) * | 1998-11-02 | 2009-08-26 | アルザ・コーポレーション | 適合性抗微生物剤を含有する電気輸送式デバイス |
US6894026B1 (en) | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
EP1121935B1 (en) * | 2000-02-04 | 2008-08-13 | Patents Exploitation Company B.V. | Pharmaceutical composition containing a small or medium size peptide |
AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
WO2003097080A1 (en) * | 2002-05-15 | 2003-11-27 | Sun Pharmaceutical Industries Limited | A stable aqueous composition of a peptide |
ITMI20021684A1 (it) | 2002-07-29 | 2004-01-29 | Therapicon Srl | Composizione farmaceutica di peptide nasale |
SI1617823T1 (sl) * | 2003-01-24 | 2019-07-31 | Nicachet Ab | Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje |
ES2236640T3 (es) | 2003-04-30 | 2005-07-16 | Ferring B.V. | Forma posologica de la desmopresina. |
US7022340B2 (en) | 2003-07-25 | 2006-04-04 | Ferring B.V. | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
EP2322195A2 (en) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
GB0406048D0 (en) | 2004-03-18 | 2004-04-21 | Ardana Bioscience Ltd | Drug formulations |
US20050244502A1 (en) | 2004-04-28 | 2005-11-03 | Mathias Neil R | Composition for enhancing absorption of a drug and method |
-
2007
- 2007-08-06 ES ES200702215A patent/ES2319054B1/es active Active
-
2008
- 2008-08-01 DK DK08805367.3T patent/DK2174652T3/en active
- 2008-08-01 US US12/672,255 patent/US8993521B2/en active Active
- 2008-08-01 ES ES08805367.3T patent/ES2608816T3/es active Active
- 2008-08-01 CN CN201610700664.8A patent/CN106265494A/zh active Pending
- 2008-08-01 BR BRPI0814835A patent/BRPI0814835B8/pt active IP Right Grant
- 2008-08-01 JP JP2010519481A patent/JP5626682B2/ja active Active
- 2008-08-01 CN CN200880105631A patent/CN101808621A/zh active Pending
- 2008-08-01 MX MX2010001456A patent/MX2010001456A/es active IP Right Grant
- 2008-08-01 SI SI200831737A patent/SI2174652T1/sl unknown
- 2008-08-01 EP EP08805367.3A patent/EP2174652B1/en active Active
- 2008-08-01 WO PCT/ES2008/000539 patent/WO2009027561A2/es active Application Filing
- 2008-08-01 HU HUE08805367A patent/HUE032667T2/en unknown
- 2008-08-01 PL PL08805367T patent/PL2174652T3/pl unknown
- 2008-08-01 LT LTEP08805367.3T patent/LT2174652T/lt unknown
- 2008-08-01 RU RU2010105031/15A patent/RU2474414C2/ru active
- 2008-08-01 PT PT88053673T patent/PT2174652T/pt unknown
- 2008-08-06 AR ARP080103430A patent/AR068337A1/es not_active Application Discontinuation
-
2016
- 2016-12-08 HR HRP20161676TT patent/HRP20161676T1/hr unknown
-
2017
- 2017-01-03 CY CY20171100005T patent/CY1118459T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP5626682B2 (ja) | 2014-11-19 |
AR068337A1 (es) | 2009-11-11 |
US20110251123A1 (en) | 2011-10-13 |
RU2010105031A (ru) | 2011-09-20 |
EP2174652B1 (en) | 2016-10-05 |
US8993521B2 (en) | 2015-03-31 |
ES2608816T3 (es) | 2017-04-17 |
DK2174652T3 (en) | 2017-01-23 |
PL2174652T3 (pl) | 2017-06-30 |
CY1118459T1 (el) | 2017-07-12 |
PT2174652T (pt) | 2016-12-23 |
BRPI0814835B1 (pt) | 2020-10-27 |
ES2319054A1 (es) | 2009-05-01 |
RU2474414C2 (ru) | 2013-02-10 |
WO2009027561A2 (es) | 2009-03-05 |
ES2319054B1 (es) | 2010-02-12 |
SI2174652T1 (sl) | 2017-04-26 |
CN101808621A (zh) | 2010-08-18 |
EP2174652A2 (en) | 2010-04-14 |
MX2010001456A (es) | 2010-06-02 |
JP2010535745A (ja) | 2010-11-25 |
HRP20161676T1 (hr) | 2017-02-24 |
CN106265494A (zh) | 2017-01-04 |
WO2009027561A3 (es) | 2009-07-16 |
BRPI0814835B8 (pt) | 2021-05-25 |
HUE032667T2 (en) | 2017-10-30 |
LT2174652T (lt) | 2017-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2140867I2 (lt) | Farmacinė kompozicija | |
LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0808889A2 (pt) | Comprimido desintegrante oral | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
EP2133095A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP2133094A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP2191826A4 (en) | PHARMACEUTICAL COMPOSITION | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
DK2966175T3 (da) | Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat | |
BRPI0812964A2 (pt) | Forma de dosagem farmacêutica oral sólida | |
BRPI0912171A2 (pt) | composição farmacêutica | |
EP2116241A4 (en) | PHARMACEUTICAL COMPOSITION | |
DK2271321T3 (da) | Farmaceutisk sammensætning 271 | |
EP2156832A4 (en) | PHARMACEUTICAL COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |